Taylor Ian 4

4 · ARVINAS, INC. · Filed Mar 4, 2022

Form 4

Period: 2022-02-23

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2022-03-04+2,686→ 84,831 total
Sale
Common Stock
2022-03-04$63.94/sh−869$55,564→ 83,962 total
Award
Stock Option (right to buy)
2022-02-23+67,000→ 67,000 total
Exercise: $64.19Exp: 2032-02-22→ Common Stock (67,000 underlying)
Exercise/Conversion
Restricted Stock Units
2022-03-04−2,686→ 2,685 total
→ Common Stock (2,686 underlying)

Footnotes (5)

[F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
[F2]This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
[F3]The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $63.94.
[F4]This option award was granted on February 23, 2022. 1/4 of the shares underlying the award shall vest on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026.
[F5]On March 1, 2019, the reporting person was granted 10,742 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.

Documents

1 file